Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.55M | -3.56M | 827.10K | -3.71M | -3.05M |
| Total Depreciation and Amortization | 16.70K | 13.70K | 13.20K | 12.90K | 8.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.70K | 14.50K | -4.99M | 770.10K | -240.50K |
| Change in Net Operating Assets | -88.60K | 970.70K | 671.00K | 385.80K | -830.00K |
| Cash from Operations | -3.58M | -2.56M | -3.48M | -2.54M | -4.12M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -1.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -1.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.00K | -13.00K | -19.00K | -- | -- |
| Issuance of Common Stock | 0.00 | 52.00K | 0.00 | 1.91M | 1.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -300.00K |
| Cash from Financing | -13.80K | 28.20K | -13.20K | 1.36M | 517.60K |
| Foreign Exchange rate Adjustments | 177.90K | -629.50K | -100.30K | 869.40K | -215.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.42M | -3.16M | -3.59M | -307.20K | -3.81M |